Press release

Planned share buyback to service the employees share subsidy program

  • High acceptance volume of approx. 50 percent globally
  • Transfer of shares in the amount of EUR 46 million to employees

As outlined in the IPO prospectus dated March 5, 2018, the participating entities within Siemens Healthineers offered a one-time share subsidy program in the context of the IPO to their eligible employees based on which the employees will receive bonus shares in addition to their own investment in shares. By the end of the offer period on July 6, 2018, the acceptance volume was excellent – globally it corresponded to approx. 50 percent of the maximum volume that could be ordered, in Germany even approx. 70 percent. “The high level of participation in our first employee share program shows just how convinced our colleagues are of the positive future of our company,” said Bernd Montag, CEO Siemens Healthineers.

In total, shares in the amount of EUR 46 million (including share bonus) will be transferred to employees. The respective share buyback to be announced shortly will be performed in the amount of up to EUR 55 million in particular in order to allow the compensation of potential share price fluctuations between share prices on the share buyback days and the reference date based on which shares have to be delivered.

Siemens Healthineers 2017

Siemens Healthineers is the separately managed healthcare business of Siemens AG enabling healthcare providers worldwide to achieve better outcomes at lower costs by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide.